Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 24

1.

Clinical and Microbiologic Outcomes in Patients with Monomicrobial Stenotrophomonas maltophilia infections.

Nys C, Cherabuddi K, Venugopalan V, Klinker KP.

Antimicrob Agents Chemother. 2019 Aug 19. pii: AAC.00788-19. doi: 10.1128/AAC.00788-19. [Epub ahead of print]

PMID:
31427300
2.

A multicenter study of the real-world use of ceftaroline versus vancomycin for acute bacterial skin and skin structure infections.

Trinh TD, Jorgensen SCJ, Zasowski EJ, Claeys KC, Lagnf AM, Estrada SJ, Delaportes DJ, Huang V, Klinker KP, Kaye KS, Davis SL, Rybak MJ.

Antimicrob Agents Chemother. 2019 Aug 12. pii: AAC.01007-19. doi: 10.1128/AAC.01007-19. [Epub ahead of print]

PMID:
31405859
3.

Towards precision dosing of vancomycin: a systematic evaluation of pharmacometric models for Bayesian forecasting.

Broeker A, Nardecchia M, Klinker KP, Derendorf H, Day RO, Marriott DJ, Carland JE, Stocker SL, Wicha SG.

Clin Microbiol Infect. 2019 Mar 11. pii: S1198-743X(19)30097-7. doi: 10.1016/j.cmi.2019.02.029. [Epub ahead of print]

PMID:
30872102
4.

Training a Drug to Do New Tricks: Insights on Stability of Meropenem Administered as a Continuous Infusion.

Venugopalan V, Manigaba K, Borgert SJ, Cope J, Peloquin CA, Klinker KP.

Microbiol Insights. 2018 Oct 14;11:1178636118804549. doi: 10.1177/1178636118804549. eCollection 2018.

5.

SCAN: A novel approach for vancomycin time-out.

Manigaba K, Borgert SJ, Klinker KP, Cherabuddi K, Venugopalan V.

Infect Control Hosp Epidemiol. 2018 Dec;39(12):1501-1503. doi: 10.1017/ice.2018.249. Epub 2018 Oct 10. No abstract available.

PMID:
30303049
6.

Preventing the Post-Antibiotic Era by Training Future Pharmacists as Antimicrobial Stewards.

Gallagher JC, Justo JA, Chahine EB, Bookstaver PB, Scheetz M, Suda KJ, Fehrenbacher L, Klinker KP, MacDougall C.

Am J Pharm Educ. 2018 Aug;82(6):6770. doi: 10.5688/ajpe6770.

7.

Assessing antimicrobial stewardship initiatives: Clinical evaluation of cefepime or piperacillin/tazobactam in patients with bloodstream infections secondary to AmpC-producing organisms.

McKamey L, Venugopalan V, Cherabuddi K, Borgert S, Voils S, Shah K, Klinker KP.

Int J Antimicrob Agents. 2018 Nov;52(5):719-723. doi: 10.1016/j.ijantimicag.2018.08.007. Epub 2018 Aug 17.

PMID:
30125680
8.

Survival in Patients with Candida glabrata Bloodstream Infection Is Associated with Fluconazole Dose.

Eschenauer GA, Carver PL, Patel TS, Lin SW, Klinker KP, Pai MP, Lam SW.

Antimicrob Agents Chemother. 2018 May 25;62(6). pii: e02566-17. doi: 10.1128/AAC.02566-17. Print 2018 Jun.

9.

Antibiotic Stewardship for Acute Exacerbation of Chronic Obstructive Pulmonary Disease.

Dietrich E, Klinker KP, Li J, Nguyen CT, Quillen D, Davis KA.

Am J Ther. 2019 Jul/Aug;26(4):e499-e501. doi: 10.1097/MJT.0000000000000717. No abstract available.

PMID:
29561269
10.

Optimization of Voriconazole Therapy for the Treatment of Invasive Fungal Infections in Adults.

Mangal N, Hamadeh IS, Arwood MJ, Cavallari LH, Samant TS, Klinker KP, Bulitta J, Schmidt S.

Clin Pharmacol Ther. 2018 Nov;104(5):957-965. doi: 10.1002/cpt.1012. Epub 2018 Feb 13.

PMID:
29315506
11.

Ampicillin for the treatment of complicated urinary tract infections caused by vancomycin-resistant Enterococcus spp (VRE): a single-center university hospital experience.

Shah KJ, Cherabuddi K, Shultz J, Borgert S, Ramphal R, Klinker KP.

Int J Antimicrob Agents. 2018 Jan;51(1):57-61. doi: 10.1016/j.ijantimicag.2017.06.008. Epub 2017 Jun 27.

PMID:
28666756
12.

Acute kidney injury risk associated with piperacillin/tazobactam compared with cefepime during vancomycin therapy in hospitalised patients: a cohort study stratified by baseline kidney function.

Jeon N, Staley B, Klinker KP, Hincapie Castillo J, Winterstein AG.

Int J Antimicrob Agents. 2017 Jul;50(1):63-67. doi: 10.1016/j.ijantimicag.2017.02.023. Epub 2017 May 15.

PMID:
28522340
13.

Impact of the CYP2C19 genotype on voriconazole exposure in adults with invasive fungal infections.

Hamadeh IS, Klinker KP, Borgert SJ, Richards AI, Li W, Mangal N, Hiemenz JW, Schmidt S, Langaee TY, Peloquin CA, Johnson JA, Cavallari LH.

Pharmacogenet Genomics. 2017 May;27(5):190-196. doi: 10.1097/FPC.0000000000000277.

14.

Multicenter Observational Study of Ceftaroline Fosamil for Methicillin-Resistant Staphylococcus aureus Bloodstream Infections.

Zasowski EJ, Trinh TD, Claeys KC, Casapao AM, Sabagha N, Lagnf AM, Klinker KP, Davis SL, Rybak MJ.

Antimicrob Agents Chemother. 2017 Jan 24;61(2). pii: e02015-16. doi: 10.1128/AAC.02015-16. Print 2017 Feb.

15.

Beyond Vancomycin: The Tail of the Lipoglycopeptides.

Klinker KP, Borgert SJ.

Clin Ther. 2015 Dec 1;37(12):2619-36. doi: 10.1016/j.clinthera.2015.11.007. Epub 2015 Dec 3. Review.

PMID:
26658277
16.

Clinical and economic impact of antimicrobial stewardship interventions with the FilmArray blood culture identification panel.

Pardo J, Klinker KP, Borgert SJ, Butler BM, Giglio PG, Rand KH.

Diagn Microbiol Infect Dis. 2016 Feb;84(2):159-64. doi: 10.1016/j.diagmicrobio.2015.10.023. Epub 2015 Nov 11.

PMID:
26639226
17.

Antimicrobial Stewardship in the Emergency Department.

Trinh TD, Klinker KP.

Infect Dis Ther. 2015 Sep;4(Suppl 1):39-50. doi: 10.1007/s40121-015-0084-8. Epub 2015 Sep 11.

18.

Prophylactic perioperative antibiotic administration: is it time to infuse our practices with new approaches?

Gravenstein N, Fish JT, Klinker KP, Coursin DB.

Anesth Analg. 2015 Apr;120(4):709-11. doi: 10.1213/ANE.0000000000000541. No abstract available.

PMID:
25790201
19.

Detection of Neisseria meningitidis from negative blood cultures and cerebrospinal fluid with the FilmArray blood culture identification panel.

Pardo J, Klinker KP, Borgert SJ, Butler BM, Rand KH, Iovine NM.

J Clin Microbiol. 2014 Jun;52(6):2262-4. doi: 10.1128/JCM.00352-14. Epub 2014 Apr 16.

20.

Large retrospective evaluation of the effectiveness and safety of ceftaroline fosamil therapy.

Casapao AM, Davis SL, Barr VO, Klinker KP, Goff DA, Barber KE, Kaye KS, Mynatt RP, Molloy LM, Pogue JM, Rybak MJ.

Antimicrob Agents Chemother. 2014 May;58(5):2541-6. doi: 10.1128/AAC.02371-13. Epub 2014 Feb 18.

21.

Real-world experience with echinocandin MICs against Candida species in a multicenter study of hospitals that routinely perform susceptibility testing of bloodstream isolates.

Eschenauer GA, Nguyen MH, Shoham S, Vazquez JA, Morris AJ, Pasculle WA, Kubin CJ, Klinker KP, Carver PL, Hanson KE, Chen S, Lam SW, Potoski BA, Clarke LG, Shields RK, Clancy CJ.

Antimicrob Agents Chemother. 2014;58(4):1897-906. doi: 10.1128/AAC.02163-13. Epub 2014 Jan 6.

22.

Measuring quality metrics to identify and monitor antimicrobial stewardship program quality improvement efforts.

Guervil DJ, Klinker KP, Reardon NT, Alnuaimat HM, Borgert SJ, Ramphal R.

Infect Control Hosp Epidemiol. 2014 Jan;35(1):101-3. doi: 10.1086/674403. No abstract available.

PMID:
24334812
23.

Time to positivity of blood cultures supports antibiotic de-escalation at 48 hours.

Pardo J, Klinker KP, Borgert SJ, Trikha G, Rand KH, Ramphal R.

Ann Pharmacother. 2014 Jan;48(1):33-40. doi: 10.1177/1060028013511229. Epub 2013 Nov 18.

PMID:
24259644
24.

Fluconazole versus an echinocandin for Candida glabrata fungaemia: a retrospective cohort study.

Eschenauer GA, Carver PL, Lin SW, Klinker KP, Chen YC, Potoski BA, Shields RK, Clancy CJ, Nguyen MH, Lam SW.

J Antimicrob Chemother. 2013 Apr;68(4):922-6. doi: 10.1093/jac/dks482. Epub 2012 Dec 4.

Supplemental Content

Loading ...
Support Center